BeiGene, Ltd. (BGNE) — Analyst outlook / Analyst consensus target is. Based on 18 analyst ratings, the consensus is bullish — 13 Buy, 4 Hold, 1 Sell.
The consensus price target is $258.00 (low: $205.00, high: $307.00), representing an upside of 39.7% from the current price $184.71.
BGNE Stock — 12-Month Price Forecast
$258.00
▲ +39.68% Upside
Average Price Target
Based on 18 Wall Street analysts offering 12-month price targets for BeiGene, Ltd., the average price target is $258.00, with a high forecast of $307.00, and a low forecast of $205.00.
The average price target represents a +39.68% change from the last price of $184.71.
Highest Price Target
$307.00
Average Price Target
$258.00
Lowest Price Target
$205.00
BGNE Analyst Ratings
Buy
Based on 18 analysts giving stock ratings to BeiGene, Ltd. in the past 3 months
